The promoter was used to drive expression of Ptpn11 containing the amino acid substitution of arginine for glutamine at position 79 in the fetal heart. This mutation results in an increase in phosphatase activity. Several lines were created and line 11 was used in subsequent experiments. Line 14 expresses the transgene at lower levels than line 11.